Use of FLT3 Inhibitors to Bridge Relapsed/Refractory AML Patients to an Allogeneic Stem Cell Transplant.

Subjects

Subjects :

*ACUTE myeloid leukemia treatment
*PROTEIN-tyrosine kinase inhibitors
*STEM cell transplantation
*CANCER relapse
*BONE marrow transplantation
*MEDICAL research

Details

Language :

English

ISSN :

10838791

Volume :

22

Database :

Academic Search Index

Journal :

Biology of Blood & Marrow Transplantation

Publication Type :

Academic Journal

Accession number :

112390427

Full Text :

https://doi.org/10.1016/j.bbmt.2015.11.589